Beijing-based Tians Pharmaceutical Co Ltd inked a deal with Japanese time-honored patch manufacturer Yutoku Pharmaceutical Ind Co Ltd, to offer high-quality overseas products to Chinese consumers.

The deal authorized Tians Pharmaceutical to serve as Yutoku's agent in China, and to sell the latter's patches on Chinese e-commerce giant JD. It is the first time that Yutoku's products, including anti-inflammatory patches and bandages, have appeared in the Chinese market.

Chen Qiang, president of Tians Pharmaceutical, said: "The launch of the products will fill in certain gaps in China's patch supply market, offering benefits to Chinese consumers while contributing to the development of China's patch manufacturing sector."

Yutoku is a renowned brand in Japan. It has developed many patch products with a large market share in Japan. Its sales network spreads across the country, offering high-quality, high-performance patches to Japanese consumers.

With its expertise in patches, the company said that it hopes to expand its distribution channel to benefit consumers worldwide.

In recent years, China has been taking advantage of cross-border e-commerce to introduce more diversified, high-quality overseas products. In March, the Ministry of Commerce and five other departments jointly issued a guideline on expanding the number of cross-border e-commerce retail pilot zones and strengthening supervision on the sector.

The MOC said that it will lay emphasis in promoting the development of cross-border e-commerce, enhancing operational guidance, and enabling the pilot zones to play a leading role in driving the import of high-quality commodities.

Gao Feng, spokesman of the MOC, said at an earlier news conference that in the future, by promoting cross-border e-commerce, the ministry will further enrich the domestic market supply, build a dynamic supply-demand balance, and accelerate the forming of the new "dual-circulation" development pattern.